| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.12 | 0.6 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.033 | 0.6 |